EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Intranasal Mometasone After External Dacryocystorhinostomy—Necessity or Convention? A Retrospective Two-Centre Cohort Study

Leticia Ortega-Evangelio, Gonzalo Roig-Ferreruela iD, Cristina Peris-Martínez iD

Journal of Clinical Medicine · 02.11.2026 · 15 (21) · 8505

DOI: 10.3390/jcm15218505 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 02.11.2026. Verfasst von Leticia Ortega-Evangelio und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Fundación Oftalmológica Médica de la Comunidad Valenciana (FOM), 46015 Valencia, Spain. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FOM/FISABIO–Carl Zeiss Meditec Iberia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Intranasal corticosteroids are frequently prescribed after dacryocystorhinostomy (DCR) to modulate mucosal healing and prevent ostium closure, but evidence supporting their use after external DCR (EXT-DCR) is scarce. This study compared early anatomical success after EXT-DCR under two centre-specific postoperative protocols that differed in the use of intranasal mometasone.

Methods

Retrospective comparative cohort study of 243 consecutive EXT-DCR procedures (211 patients) for distal lacrimal obstruction performed by a single surgeon using the same technique at two centres between 2019 and 2025. Postoperative treatment was determined by each centre’s standing protocol: both included oral amoxicillin–clavulanic acid for one week, and one centre additionally prescribed intranasal mometasone furoate twice daily for two months (mometasone group, n = 64; control group, n = 179). The primary outcome was anatomical success, defined as lacrimal patency on irrigation at two months. Groups were compared with Fisher’s exact test and a multivariable logistic regression adjusted for age and sex.

Results

Anatomical success was 93.8% (60/64) in the mometasone group and 89.9% (161/179) in the control group (absolute difference 3.8 percentage points; 95% CI −5.7 to 10.3; p = 0.45). After adjustment for age and sex, treatment group was not significantly associated with success (control vs. mometasone: OR 0.57; 95% CI 0.18–1.77; p = 0.33). No statistically significant associations were detected for age or sex.

Conclusions

In this cohort, adding a two-month course of intranasal mometasone to standard postoperative care after EXT-DCR was not associated with a statistically significant improvement in early anatomical success. Given the limited statistical power and a confidence interval that does not exclude a clinically meaningful benefit, this absence of a significant difference does not establish therapeutic equivalence. Adequately powered prospective trials with longer follow-up are needed before routine intranasal corticosteroid use after EXT-DCR can be either recommended or abandoned.

Schlagwörter

Stichwörter der Autor:innen

dacryocystorhinostomyepiphoraexternal dacryocystorhinostomyintranasal corticosteroidsmometasone furoatenasolacrimal duct obstructionpostoperative care

Autor:innen und Institutionen

  • Department of Ophthalmology, Fundación Oftalmológica Médica de la Comunidad Valenciana (FOM), 46015 Valencia, Spain.
  • Department of Oculoplastics, Clínica Baviera, 46005 Valencia, Spain.
  • Surgery Department, Ophthalmology, School of Medicine, University of Valencia, Av. Blasco Ibáñez 15, 46010 Valencia, Spain.
  • Spanish Network of Inflammatory Diseases: REI-RICORS (RD24/0007/0004) of the Institute of Health Carlos III (ISCIII), Spanish Government, 28029 Madrid, Spain.

ORCID-Profile: Gonzalo Roig-Ferreruela, Cristina Peris-Martínez

Förderung

  • FOM/FISABIO–Carl Zeiss Meditec Iberia

Zitieren

APA

Ortega-Evangelio, L., Roig-Ferreruela, G., & Peris-Martínez, C. (2026). Intranasal Mometasone After External Dacryocystorhinostomy—Necessity or Convention? A Retrospective Two-Centre Cohort Study. Journal of Clinical Medicine, 15(21), 8505. https://doi.org/10.3390/jcm15218505

Vancouver

Ortega-Evangelio L, Roig-Ferreruela G, Peris-Martínez C. Intranasal Mometasone After External Dacryocystorhinostomy—Necessity or Convention? A Retrospective Two-Centre Cohort Study. Journal of Clinical Medicine. 2026;15(21):8505. doi:10.3390/jcm15218505

BibTeX
@article{OrtegaEvangelio2026,
  author = {Ortega-Evangelio, Leticia and Roig-Ferreruela, Gonzalo and Peris-Martínez, Cristina},
  title = {Intranasal Mometasone After External Dacryocystorhinostomy—Necessity or Convention? A Retrospective Two-Centre Cohort Study},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {21},
  pages = {8505},
  doi = {10.3390/jcm15218505}
}
Kostenlos starten →